A Case of Idiopathic Myelofibrosis Associated with Acromegaly Patient.
10.3803/jkes.2006.21.4.328
- Author:
Jun Young SONG
1
;
Pyoung Rak CHOI
;
Hong Jun YOU
;
Seong Hoon SHIN
;
Yu Ri KIM
;
Young Sik CHOI
;
Yo Han PARK
;
Mi Hyang KIM
;
Bong Kwon CHUN
;
Young Duk JOH
Author Information
1. Department of Internal Medicine, Kosin University College of Medicine, Korea.
- Publication Type:Case Report
- Keywords:
Acromegaly;
Low dose thalidomide;
Myelofibrosis
- MeSH:
Acromegaly*;
Growth Hormone;
Hematologic Neoplasms;
Humans;
Insulin;
Male;
Middle Aged;
Pituitary Neoplasms;
Prednisone;
Primary Myelofibrosis*;
Thalidomide
- From:Journal of Korean Society of Endocrinology
2006;21(4):328-332
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Acromegaly is a chronic condition resulting from the excessive secretion of growth hormone and insulin like growth factor 1, generally from pituitary adenoma. Although there have been several reports suggesting the possible association of hematologic malignancies with acromegaly, myelofibrosis with acromegaly is very rare. Here we report 54-year-old male patient with myelofibrosis accompanied with acromegaly. We treated this patient with low dose thalidomide (50 mg/day) and prednisone (30 mg/day). We reported this case with literature review.
